Bio-Techne (TECH) insider trading

By person

25 insiders · 302 transactions

4.2×

Kim Kelderman holds only 4.2 times base salary in stock. $4.00M of shares against $936.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Kim Kelderman last reported holding, valued at $48.28, the price Common Stock was last bought or sold at on the open market here, on 8 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Hippel James

CFO

—

$60.15M (77) scheduled

−$60.15M

170,183

0.1087%

$8.22M

+300.0%

Kummeth Charles R.

Chief Executive Officer

$37.00K (2)

$52.19M (34) scheduled

−$52.16M

1,278,369

0.8165%

$61.72M

+63.4%

Eansor Norman David

President-Protein Sciences

—

$37.41M (30) scheduled

−$37.41M

2,117

0.0014%

$102.21K

−46.2%

Furlow Brenda S.

SVP - GENERAL COUNSEL

—

$22.52M (30) scheduled

−$22.52M

27,422

0.0175%

$1.32M

+35.9%

Nusse Roeland

Director

—

$8.55M (6) scheduled

−$8.55M

44,559

0.0285%

$2.15M

+135.1%

BAUMGARTNER ROBERT V

Director

$201.30K (2)

$8.50M (15) scheduled

−$8.29M

46,503

0.0297%

$2.25M

+24.4%

HIGGINS JOHN L

Director

—

$7.29M (14) scheduled

−$7.29M

66,876

0.0427%

$3.23M

+254.2%

STEER RANDOLPH C

Director

—

$7.10M (9) scheduled

−$7.10M

24,201

0.0155%

$1.17M

+27.4%

WIENS HAROLD J

Director

—

$3.44M (7) scheduled

−$3.44M

4,843

0.0031%

$233.82K

+89.3%

Kelderman Kim

Chief Executive Officer

—

$2.75M (8)

−$2.75M

82,762

0.0529%

$4.00M

+625.8%

Dinarello Charles A

Director

—

$2.12M (4) scheduled

−$2.12M

8,212

0.0052%

$396.48K

+25.2%

Seth Alpna

Director

—

$1.54M (2) scheduled

−$1.54M

15,411

0.0098%

$744.04K

+92.3%

HOLBROOK KAREN A

Director

—

$791.42K (3) scheduled

−$791.42K

914

0.0006%

$44.13K

−55.6%

Herr Amy E.

Director

—

$623.57K (4) scheduled

−$623.57K

3,256

0.0021%

$157.20K

+75.1%

LUCAS ROGER C

Director

—

$259.78K (16)

−$259.78K

1,870

0.0012%

$90.28K

−43.6%

Geist William

PRESIDENT, PROTEIN SCIENCES

—

24,943

0.0159%

$1.20M

+715.1%

KEEGAN JOSEPH D

Director

—

15,411

0.0098%

$744.04K

+92.3%

Vessey Rupert

Director

—

10,987

0.0070%

$530.45K

+134.0%

Bohnen Shane

SVP - General Counsel

—

10,360

0.0066%

$500.18K

+7,574%

Crouse Steven C.

President - Diag & Spatial Bi

—

10,237

0.0065%

$494.24K

+73.7%

Bushman Julie L

Director

—

8,775

0.0056%

$423.66K

+189.0%

McManus Matthew

President - Diag & Spatial Bio

—

7,691

0.0049%

$371.32K

—

Klimovsky Judith V.

Director

—

3,782

0.0024%

$182.59K

—

Gavin Robert M.

Sen. VP Protein Platforms

—

1,667

0.0011%

$80.48K

—

Gould Kevin S

SVP Clinical Controls

—

1,355

0.0009%

$65.42K

−18.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Herr Amy E.

17 Feb 2026

Director

Sell indirect

1,976

$59.11

$116.79K

Nusse Roeland

7 Mar 2024

Director

Sell

10,400

$76.98

$800.63K

Kummeth Charles R.

7 Jun 2023

Chief Executive Officer

Sell

322

$83.00

$26.73K

HIGGINS JOHN L

11 Aug 2022

Director

Sell

$380.71

$3.05K

HIGGINS JOHN L

11 Aug 2022

Director

Sell

504

$385.47

$194.28K

Hippel James

28 Oct 2021

Chief Financial Officer

Sell

100

$525.18

$52.52K

Kelderman Kim

22 Sep 2021

Pres. Diagnostics & Genom

Sell

822

$529.04

$434.87K

Eansor Norman David

31 Aug 2021

President-Protein Sciences

Sell

1,538

$503.07

$773.73K

Kummeth Charles R.

18 Jun 2021

Chief Executive Officer

Sell

326

$450.37

$146.82K

Kummeth Charles R.

18 Jun 2021

Chief Executive Officer

Sell

2,583

$449.09

$1.16M

Kummeth Charles R.

17 Jun 2021

Chief Executive Officer

Sell

109

$452.13

$49.28K

Kummeth Charles R.

17 Jun 2021

Chief Executive Officer

Sell

1,050

$451.54

$474.12K

Kummeth Charles R.

17 Jun 2021

Chief Executive Officer

Sell

1,698

$450.39

$764.76K

Kummeth Charles R.

17 Jun 2021

Chief Executive Officer

Sell

6,732

$449.35

$3.03M

Kummeth Charles R.

14 Jun 2021

Chief Executive Officer

Sell

349

$450.10

$157.08K

Kummeth Charles R.

14 Jun 2021

Chief Executive Officer

Sell

7,132

$449.10

$3.20M

Kelderman Kim

9 Jun 2021

Pres. Diagnostics & Genom

Sell

811

$433.00

$351.16K

Kelderman Kim

25 May 2021

Pres. Diagnostics & Genom

Sell

845

$424.00

$358.28K

Kelderman Kim

5 Feb 2021

Pres. Diagnostics & Genom

Sell

823

$388.45

$319.69K

Kummeth Charles R.

15 Jan 2021

Chief Executive Officer

Sell

20,000

$344.00

$6.88M

Kummeth Charles R.

7 Dec 2020

Chief Executive Officer

Sell

5,000

$308.00

$1.54M

Eansor Norman David

4 Mar 2020

President-Protein Sciences

Sell

1,387

$198.68

$275.57K

Showing 250 of 302 transactions. The figures above use every one of them.

Bio-Techne

By person

Individual transactions

What was left out